Cargando…

Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non–small-cell lung carcinoma

Epigenetic alterations are crucial to oncogenesis and regulation of gene expression in non–small-cell lung carcinoma (NSCLC). DNA methylation (DNAm) biomarkers may provide molecular-level prediction of relapse risk in cancer. Identification of optimal treatment is warranted for improving clinical ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ruihan, Song, Jing, Xiao, Xiao, Xie, Zhengbo, Zhao, Zhiyuan, Zhang, Wanfeng, Miao, Shiqi, Tang, Yongyao, Ran, Longke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425482/ https://www.ncbi.nlm.nih.gov/pubmed/32723974 http://dx.doi.org/10.18632/aging.103517

Ejemplares similares

Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma
por: Song, Jing, et al.
Publicado: (2019)

CimpleG: finding simple CpG methylation signatures
por: Maié, Tiago, et al.
Publicado: (2023)

Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)

Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015)

Identification of genetic variations associated with drug resistance in non-small cell lung cancer patients undergoing systemic treatment
por: Luo, Ruihan, et al.
Publicado: (2021)

The Effects of O(6)-methyl Guanine DNA-methyl Transferase Promotor Methylation and CpG1, CpG2, CpG3 and CpG4 Methylation on Treatment Response and their Prognostic Significance in Patients with Glioblastoma
por: Yildiz, OG, et al.
Publicado: (2020)

In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases
por: Arand, Julia, et al.
Publicado: (2012)

CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function
por: Jang, Hyun Sik, et al.
Publicado: (2017)

Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response
por: Song, Jing, et al.
Publicado: (2021)

CpG methylation signature defines human temporal lobe epilepsy and predicts drug‐resistant
por: Xiao, Wenbiao, et al.
Publicado: (2020)

CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen, Wenqiang, et al.
Publicado: (2021)

CpG Methylation Altered the Stability and Structure of the i-Motifs Located in the CpG Islands
por: Oshikawa, Daiki, et al.
Publicado: (2022)

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
por: Decock, Anneleen, et al.
Publicado: (2015)

The Control Region of Mitochondrial DNA Shows an Unusual CpG and Non-CpG Methylation Pattern
por: Bellizzi, Dina, et al.
Publicado: (2013)

Evaluation of single CpG sites as proxies of CpG island methylation states at the genome scale
por: Barrera, Víctor, et al.
Publicado: (2012)

Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
por: Goldsmith, Chloe, et al.
Publicado: (2021)

Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015)

The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018)

Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation
por: Padmanabhan, Nisha, et al.
Publicado: (2021)

A five‐CpG signature of microRNA methylation in non‐G‐CIMP glioblastoma
por: Kang, En‐Ming, et al.
Publicado: (2019)

Methyl CpG binding protein 2 (MeCP2) enhances photodimer formation at methyl-CpG sites but suppresses dimer deamination
por: Cannistraro, Vincent J., et al.
Publicado: (2010)

Prognostic value of CpG island methylator phenotype in gastric cancer
por: Xiao, Huashi, et al.
Publicado: (2018)

Deoxyribonucleic acid methylation profiling of single human blastocysts by methylated CpG-island amplification coupled with CpG-island microarray
por: Huntriss, John, et al.
Publicado: (2015)

Cytosine methylation at CpCpG sites triggers accumulation of non-CpG methylation in gene bodies
por: Zabet, Nicolae Radu, et al.
Publicado: (2017)

Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma
por: Lai, Jiayi, et al.
Publicado: (2023)

Genomics of CpG Methylation in Developing and Developed Zebrafish
por: McGaughey, David M., et al.
Publicado: (2014)

CpG Distribution and Methylation Pattern in Porcine Parvovirus
por: Tóth, Renáta, et al.
Publicado: (2013)

CpG methylation patterns of human mitochondrial DNA
por: Liu, Baojing, et al.
Publicado: (2016)

Different Methylation of CpG-SNPs in Behcet's Disease
por: Huang, Yang, et al.
Publicado: (2019)

DNA CpG methylation in sequential glioblastoma specimens
por: Kraboth, Zoltan, et al.
Publicado: (2020)

CpG Methylation in Aging: Trajectories of Individual Sites
por: Meer, Margarita, et al.
Publicado: (2020)

Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
por: Zhang, Rui-kun, et al.
Publicado: (2021)

5-Halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2)
por: Valinluck, Victoria, et al.
Publicado: (2005)

SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy
por: Li, Xin, et al.
Publicado: (2019)

Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005)

Substitution rate variation at human CpG sites correlates with non-CpG divergence, methylation level and GC content
por: Mugal, Carina F, et al.
Publicado: (2011)

Dynamic bimodal changes in CpG and non-CpG methylation genome-wide upon CGGBP1 loss-of-function
por: Patel, Divyesh, et al.
Publicado: (2018)

Prediction model construction of mouse stem cell pluripotency using CpG and non-CpG DNA methylation markers
por: Joe, Soobok, et al.
Publicado: (2020)

Engineering CpG island DNA methylation in pluripotent cells through synthetic CpG-free ssDNA insertion
por: Tompkins, Joshua, et al.
Publicado: (2023)

Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant
por: Wei, Jingjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gu7tjsljrnaqb1qbqvdeu5gvue